Profund Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14M Buy
110,868
+3,435
+3% +$453K 0.39% 37
2026
Q1
$15M Sell
107,433
-28,520
-21% -$3.99M 0.55% 30
2025
Q4
$16.7M Buy
135,953
+15,824
+13% +$1.92M 0.51% 31
2025
Q3
$13.3M Sell
120,129
-5,818
-5% -$661K 0.43% 36
2025
Q2
$14M Buy
125,947
+9,252
+8% +$985K 0.5% 30
2025
Q1
$13.1M Sell
116,695
-21,005
-15% -$2.17M 0.57% 28
2024
Q4
$12.7M Sell
137,700
-4,902
-3% -$441K 0.46% 34
2024
Q3
$12M Sell
142,602
-16,798
-11% -$1.28M 0.45% 36
2024
Q2
$10.9M Buy
159,400
+30,738
+24% +$2.05M 0.41% 39
2024
Q1
$9.42M Sell
128,662
-7,013
-5% -$539K 0.37% 45
2023
Q4
$11M Buy
135,675
+18,318
+16% +$1.43M 0.47% 35
2023
Q3
$8.79M Buy
117,357
+23,312
+25% +$1.79M 0.49% 32
2023
Q2
$7.25M Buy
94,045
+7,367
+8% +$588K 0.39% 35
2023
Q1
$7.19M Sell
86,678
-114,960
-57% -$9.52M 0.44% 30
2022
Q4
$17.3M Buy
201,638
+335
+0.2% +$26.5K 1.12% 14
2022
Q3
$12.4M Sell
201,303
-10,871
-5% -$686K 0.89% 18
2022
Q2
$13.1M Sell
212,174
-29,199
-12% -$1.81M 0.83% 19
2022
Q1
$14.3M Sell
241,373
-45,629
-16% -$2.92M 0.6% 26
2021
Q4
$20.8M Sell
287,002
-35,997
-11% -$2.48M 0.68% 26
2021
Q3
$22.6M Sell
322,999
-1,105
-0.3% -$77.6K 0.76% 20
2021
Q2
$22.3M Sell
324,104
-10,068
-3% -$672K 0.75% 21
2021
Q1
$21.6M Sell
334,172
-6,286
-2% -$405K 0.83% 19
2020
Q4
$19.8M Buy
340,458
+25,718
+8% +$1.55M 0.87% 18
2020
Q3
$19.9M Sell
314,740
-41,389
-12% -$2.87M 1.02% 15
2020
Q2
$27.4M Buy
356,129
+41,744
+13% +$3.2M 1.52% 10
2020
Q1
$23.5M Sell
314,385
-109,207
-26% -$7.55M 1.76% 10
2019
Q4
$27.5M Buy
423,592
+43,945
+12% +$2.86M 1.2% 11
2019
Q3
$24.1M Sell
379,647
-23,146
-6% -$1.51M 1.22% 11
2019
Q2
$27.2M Sell
402,793
-31,371
-7% -$2.06M 1.29% 9
2019
Q1
$28.2M Buy
434,164
+846
+0.2% +$56.2K 1.36% 11
2018
Q4
$27.1M Sell
433,318
-109,915
-20% -$7.68M 1.68% 9
2018
Q3
$41.9M Buy
543,233
+45,259
+9% +$3.42M 1.59% 9
2018
Q2
$35.3M Sell
497,974
-29,502
-6% -$2.08M 1.41% 11
2018
Q1
$39.8M Sell
527,476
-39,037
-7% -$3.1M 1.58% 9
2017
Q4
$40.6M Sell
566,513
-61,327
-10% -$4.66M 1.56% 8
2017
Q3
$50.9M Buy
627,840
+42,065
+7% +$3.22M 2.12% 5
2017
Q2
$41.5M Sell
585,775
-32,696
-5% -$2.18M 1.88% 8
2017
Q1
$42M Sell
618,471
-46,184
-7% -$3.25M 1.88% 6
2016
Q4
$47.6M Sell
664,655
-94,038
-12% -$6.99M 2.19% 2
2016
Q3
$60M Sell
758,693
-38,416
-5% -$3.12M 2.86% 2
2016
Q2
$66.5M Sell
797,109
-61,062
-7% -$5.42M 3.24% 2
2016
Q1
$78.8M Sell
858,171
-254,379
-23% -$22.9M 4.09% 1
2015
Q4
$113M Sell
1,112,550
-16,941
-1% -$1.76M 5.34% 1
2015
Q3
$111M Sell
1,129,491
-67,551
-6% -$7.5M 6.32% 1
2015
Q2
$140M Sell
1,197,042
-29,680
-2% -$3.24M 5.8% 1
2015
Q1
$120M Buy
1,226,722
+48,251
+4% +$4.9M 4.68% 1
2014
Q4
$111M Buy
1,178,471
+114,398
+11% +$11.8M 4.55% 1
2014
Q3
$113M Buy
1,064,073
+62,234
+6% +$6.09M 5.31% 1
2014
Q2
$83.1M Sell
1,001,839
-252,967
-20% -$19.7M 3.64% 1
2014
Q1
$88.9M Buy
1,254,806
+213,600
+21% +$16.8M 4.04% 1
2013
Q4
$78.2M Buy
1,041,206
+207,621
+25% +$14.5M 3.51% 1
2013
Q3
$52.4M Buy
833,585
+44,482
+6% +$2.66M 2.78% 1
2013
Q2
$40.4M Buy
+789,103
New +$41.1M 2.86% 1

Other funds holding GILD

Profund Advisors's GILD Position: Q2 2026 in Review

Profund Advisors increased its Gilead Sciences (GILD) stake by 3.2% in Q2 2026, buying an estimated $453K and bringing the position to 110,868 shares worth $14M. The position accounts for 0.39% of the portfolio, ranked #37.

Profund Advisors first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $140M in Q2 2015. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Profund Advisors held 110,868 shares of Gilead Sciences worth $14M as of Q2 2026.
  • Profund Advisors bought 3,435 Gilead Sciences shares in Q2 2026, an estimated $453K.
  • Gilead Sciences made up 0.39% of Profund Advisors's portfolio in Q2 2026, its #37 holding.
  • Profund Advisors first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
  • Profund Advisors's Gilead Sciences position peaked at $140M in Q2 2015.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Profund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.